Kohlberg & Company Recapitalizes Trinity Life Sciences

November 30, 2021

Kohlberg & Company will recapitalize Trinity Life Sciences, replacing Parthenon Capital as the company’s capital partner. The transaction provides Trinity with new growth capital to support global expansion, technology and data-driven capability investments while Trinity’s management team, led by CEO David Fitzhenry, will remain in place.

Targets
Trinity Life Sciences
Sellers
Parthenon Capital
Location
Massachusetts, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.